文献速递神经PETCT

胶质瘤中18F-DOPA摄取参数:患者特征与既往治疗史的影响

18F-DOPA uptake parameters in glioma: effects of patients' characteristics and prior treatment history.
PubMed 文献 · Br J Radiol · 2018-01-19

本研究分析120例胶质瘤患者的155次18F-氟-L-苯丙氨酸PET/CT检查,比较替莫唑胺化疗前、后及化疗期间正常脑本底和肿瘤-脑比值的变化。结果显示替莫唑胺化疗及患者性别、年龄影响生理性氨基酸摄取,进而影响肿瘤-脑比值的计算。

要点

  • 女性正常本底和基底节摄取显著高于男性,年龄与基底节摄取正相关。
  • 化疗期间组正常本底摄取低于化疗后组,肿瘤-脑比值高于化疗后组。
  • 评估肿瘤-脑比值时需考虑替莫唑胺化疗状态及患者性别、年龄的影响。

核心结论

  • 替莫唑胺化疗及患者性别、年龄影响生理性18F-氟-L-苯丙氨酸摄取,进而影响肿瘤-脑比值的计算,评估肿瘤-本底比值时应予考虑。

研究设计与样本

  • 分析120例胶质瘤患者的155次18F-氟-L-苯丙氨酸PET/CT检查,按替莫唑胺治疗状态分为化疗前组(A组,n=48)、化疗后组(B组,n=50)和化疗期间组(C组,n=57),采用方差分析比较各组参数。

诊断标准与关键数值

  • 总体平均本底标准化摄取值(SUVbckgr)为1.06±0.26,平均基底节标准化摄取值(SUVbg)为2.12±0.47;化疗期间组SUVbckgr为1.00±0.25,低于化疗后组的1.14±0.31(p=0.0173);化疗期间组肿瘤-脑比值(TBR)为2.37±0.54,高于化疗后组的2.06±0.38(p=0.010)。

临床应用与阅片要点

  • 作者认为,替莫唑胺化疗及性别、年龄对生理性氨基酸摄取的影响具有相关性,在评估肿瘤-本底比值时应予以考虑。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: In amino acid positron emission tomography brain tumour imaging, tumour-to-background uptake parameters are often used for treatment monitoring. We studied the effects of patients' characteristics and anticancer treatments on 18F-fluoro-l-phenylalanine uptake of normal brain and tumour lesions, with particular emphasis on temozolomide (TMZ) chemotherapy.

METHODS: 155 studies from 120 patients with glioma were analysed. Average uptake of normal background (standardized uptake value, SUVbckgr) and basal ganglia (SUVbg), as well as tumour-to-brain ratios (TBR) were compared between positron emission tomography/CT studies acquired before (Group A, n = 48), after (Group B, n = 50) or during (Group C, n = 57) TMZ treatment, using analysis of variance.

RESULTS: Overall, mean SUVbckgr and mean SUVbg were 1.06 ± 0.26 and 2.12 ± 0.47, respectively. Female had significantly higher SUVbckgr (p = 0.002) and SUVbg (p = 0.012) than male patients. Age showed a positive correlation with SUVbg (p = 0.001). In the overall cohort, there were significant effects of TMZ on SUVbckgr (p = 0.0237) and TBR (p = 0.0138). In particular, SUVbckgr was lower in Group C than in Group B (1.00 ± 0.25 vs 1.14 ± 0.31, p = 0.0173). Significant variations of SUVbckr could be observed in female only. TBR was significantly higher in Group C than in Group B (2.37 ± 0.54 vs 2.06 ± 0.38, p = 0.010). Variations of SUVbg between groups slightly missed significance (p = 0.0504).

CONCLUSION: Temozolomide chemotherapy and patients' characteristics, including gender and age, affect physiological [18F]-fluoro-l-phenylalanine uptake and, consequently, the calculation of TBRs. Advances in knowledge: For the first time, the effects of past or concurrent temozolomide chemotherapy on brain physiological amino acid uptake have been investigated. Such effects are relevant and should be taken into account when evaluating tumour-to-background ratios.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Carideo L, Minniti G, Mamede M, et al. 18F-DOPA uptake parameters in glioma: effects of patients' characteristics and prior treatment history. Br J Radiol. 2018. PMID: 29271230. doi:10.1259/bjr.20170847

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。